Lyme disease vaccine shows 70 percent efficacy, Pfizer says

Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies developing the shot....

Redirecting to full article...